Back to 
AVIVA PLC
AVIVA PLC
AMLX
Showing 1 of 3 quarters
Position history for AVIVA PLC's holdings in AMYLYX PHARMACEUTICALS INC
No. Aviva exited its AMLX (Amylyx Pharmaceuticals) position in Q3 2024. Its Q2 2024 13F listed 363,032 shares worth $689,761. Aviva first reported AMLX in Q1 2024 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History